• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Plastikos Medical Begins Phase II of Expansion

    Ready Robotics Hires Proven Automation Leaders

    Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety

    FDA OKs Asensus' Senhance for General Surgery

    Boston Scientific to Buy Lumenis' Surgical Biz for $1B
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Role and Benefits of Plastics in the COVID-19 Vaccine Rollout

    Six Questions to Consider in Developing a Home Healthcare Device

    Five Themes to Watch as Digital Health Takes Center Stage

    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    K-Tube Technologies

    Concise Engineering

    Spectrum Plastics Group

    Medicoil

    maxon
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    FUTEK Advanced Sensor Technology Inc.

    Medicoil

    Forefront Medical Technology

    Spectrum Plastics Group
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    New Research Sheds Light on Potential Glaucoma Treatment

    Hydrogels could provide an alternative to drugs or surgery.

    New Research Sheds Light on Potential Glaucoma Treatment
    A microneedle less than a millimeter in length is used to inject a natural and biodegradable polymer material into a structure in the eye. The material forms a hydrogel that holds open a pathway to release pressure from the eye. Image courtesy of Gary Meek, Georgia Tech.
    Related CONTENT
    • NAMSA Acquires American Preclinical Services
    • Memic Receives FDA Marketing Authorization for Hominis
    • Olympus to Purchase Israeli Firm Medi-Tate to Grow Urology Biz
    • FDA Breakthrough Device Designation Awarded to BrainCool AB's Cooral System
    • Solid Growth Forecast for Japan's MI Neurosurgical Devices Market
    Georgia Institute of Technology12.07.20
    Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eyedrops and surgery with a twice-a-year injection to control the buildup of pressure in the eye. The researchers envision the injection being done as an office procedure that could be part of regular patient visits.
     
    The possible treatment, which could become the first non-drug, non-surgical, long-acting therapy for glaucoma, uses the injection of a natural and biodegradable material to create a viscous hydrogel — a water-absorbing crosslinked polymer structure — that opens an alternate pathway for excess fluid to leave the eye. 
     
    ‘The Holy Grail for Glaucoma’
    “The holy grail for glaucoma is an efficient way to lower the pressure that doesn’t rely on the patient putting drops in their eyes every day, doesn’t require a complicated surgery, has minimal side effects, and has a good safety profile,” said Ross Ethier, professor and Georgia Research Alliance Lawrence L. Gellerstedt Jr. Eminent Scholar in Bioengineering in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. “I am excited about this technique, which could be a game-changer for the treatment of glaucoma.”
     
    The research, which was supported by the National Eye Institute and the Georgia Research Alliance, was published Dec. 7 in the journal Advanced Science. The research was conducted in animals, and shows that the approach significantly lowered the intraocular pressure.
     
    As many as 75 million people worldwide have glaucoma, which is the leading cause of irreversible blindness. Glaucoma damage is caused by excess pressure in the eye that injures the optic nerve. Current treatments attempt to reduce this intraocular pressure through the daily application of eyedrops, or through surgery or implantation of medical devices, but these treatments are often unsuccessful.
     
    Developing an Alternative Treatment for Glaucoma
    To provide an alternative, Ethier teamed up with Mark Prausnitz, professor and J. Erskine Love Jr. chair in the School of Chemical and Biomolecular Engineering at Georgia Tech, to use a tiny hollow needle to inject a polymer preparation into a structure just below the surface of the eye called the suprachoroidal space (SCS). Inside the eye, the material chemically crosslinks to form the hydrogel, which holds open a channel in the SCS that allows aqueous humor from within the eye to drain out of the eye through the alternative pathway.
     
    There are normally two pathways for the aqueous humor fluid to leave the eye. The dominant path is through a structure known as the trabecular meshwork, which is located at the front of the eye. The lesser pathway is through the SCS, which normally has only a very small gap. In glaucoma, the dominant pathway is blocked, so to lessen pressure, treatments are created to open the lesser pathway enough to let the aqueous humor flow out.
     
    In this research, the hydrogel props open the SCS path. A hollow microneedle less than a millimeter long is used to inject a droplet (about 50 microliters) of the hydrogel-precursor material. That gel structure can keep the SCS pathway open for a period of months.
     
    “We inject a viscous material and keep it at the site of the injection at the interface between the back of the eye and the front of the eye where the suprachoroidal space begins,” Prausnitz said. “By opening up that space, we tap a pathway that would not otherwise be utilized efficiently to remove liquid from the eye.”
     
    The injection would take just a few minutes, and would involve a doctor making a small injection just below the surface of the eye in combination with numbing and cleaning the injection site. In the study, the researchers, including veterinary ophthalmologist and first author J. Jeremy Chae, did not observe significant inflammation resulting from the procedure.
     
    Conclusions
    The pressure reduction was sustained for four months. The researchers are now working to extend that time by modifying the polymer material — hyaluronic acid — with a goal of providing treatment benefits for at least six months. That would coincide with the office visit schedule of many patients.
     
    “If we can get to a twice-a-year treatment, we would not disrupt the current clinical process,” Prausnitz said. “We believe the injection could be done as an office procedure during routine exams that the patients are already getting. Patients may not need to do anything to treat their glaucoma until their next office visit.”
     
    Beyond extending the time between treatments, the researchers will need to demonstrate that the injection can be repeated without harming the eye. The procedure will also have to be tested in other animals before moving into human trials.
     
    “The idea of having a ‘one-and-done’ treatment that lasts for six months would be particularly helpful for those whose access to healthcare is non-optimal,” Ethier said. “Having a long-acting therapy would have an additional advantage during times of pandemic or other disruption when access to healthcare is more difficult.”
     
    This research was supported by a grant from the National Eye Institute (R01 EY025286) and by the Georgia Research Alliance.
      
    Reference:
    J. Jeremy Chae, et al., “Drug-free, Non-surgical Reduction of Intraocular Pressure for Four Months After Suprachoroidal Injection of Hyaluronic Acid Hydrogel.” (Advanced Science, 2020) https://doi.org/10.1002/advs.202001908
    Related Searches
    • Chronic Disease
    Related Knowledge Center
    • Chronic Disease
    Suggested For You
    NAMSA Acquires American Preclinical Services NAMSA Acquires American Preclinical Services
    Memic Receives FDA Marketing Authorization for Hominis Memic Receives FDA Marketing Authorization for Hominis
    Olympus to Purchase Israeli Firm Medi-Tate to Grow Urology Biz Olympus to Purchase Israeli Firm Medi-Tate to Grow Urology Biz
    FDA Breakthrough Device Designation Awarded to BrainCool AB FDA Breakthrough Device Designation Awarded to BrainCool AB's Cooral System
    Solid Growth Forecast for Japan Solid Growth Forecast for Japan's MI Neurosurgical Devices Market
    Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid
    Axonics Buys Contura to Expand to Stress Urinary Incontinence Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Mike on Medtech: Update on FDA Mike on Medtech: Update on FDA's STeP Designation
    FDA Clears Ava Fertility Tracking Wearable Device FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Refurbished Medical Equipment Testing and Certification Under the NEC Refurbished Medical Equipment Testing and Certification Under the NEC
    Japan to Lead APAC Assisted Reproductive Technology Devices Market Japan to Lead APAC Assisted Reproductive Technology Devices Market
    Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump
    Millstone Medical Outsourcing Reaches 600-Employee Milestone Millstone Medical Outsourcing Reaches 600-Employee Milestone

    Related Breaking News

    • Chronic Disease
      January AI Raises $8.8 Million in New Funding

      January AI Raises $8.8 Million in New Funding

      New technology can predict users’ glycemic response to over 16 million foods in its proprietary atlas.
      Charles Sternberg, Assistant Editor 02.26.21

    • Chronic Disease | Digital Health | Patient Monitoring
      Teladoc Health, Dexcom Launch CGM Tech, Personalized Insights for Type 2 Diabetes

      Teladoc Health, Dexcom Launch CGM Tech, Personalized Insights for Type 2 Diabetes

      CGM-powered insights offer complete health profile, recommendations that support ongoing diabetes management.
      GlobeNewswire 01.13.21

    • Chronic Disease | Diagnostics
      Hologic to Buy Cancer Test Maker Biotheranostics for $230M

      Hologic to Buy Cancer Test Maker Biotheranostics for $230M

      Accelerates Hologic’s entry into the oncology growth market, provides new lab capabilities.
      Business Wire 01.06.21


    • Chronic Disease
      Medtronic

      Medtronic's OsteoCool Procedure Shows Significant Pain Relief in Cancer Patients

      Patients had significant and swift improvement in pain relief at just three days post-procedure.
      PR Newswire 12.15.20

    • Chronic Disease
      Medtronic Launches Pediatric/Neonatal Acute Dialysis Machine

      Medtronic Launches Pediatric/Neonatal Acute Dialysis Machine

      The Carpediem system is designed to treat patients requiring renal replacement therapy weighing between 2.5 and 10 kilograms (5.5 to 22 pounds).
      PR Newswire 12.08.20

    • Chronic Disease | Patient Monitoring
      FDA OKs Baxter

      FDA OKs Baxter's Homechoice Claria with Sharesource

      Sharesource is a two-way remote patient management platform for patients on peritoneal dialysis.
      Business Wire 11.23.20


    • Chronic Disease
      Varian Begins First Human Trial of FLASH Therapy for Cancer

      Varian Begins First Human Trial of FLASH Therapy for Cancer

      ProBeam particle accelerator was modified to enable radiation therapy delivery at ultra-high dose rates.
      PR Newswire 11.20.20

    • Chronic Disease | Diagnostics
      FDA Clears Lantheus

      FDA Clears Lantheus' AI-Enabled Bone Scan Index in Prostate Cancer

      Lantheus' software cleared for use on GE Healthcare Xeleris Platform.
      Business Wire 11.13.20

    • Chronic Disease
      Medtronic Launches InPen with Real-Time Guardian Connect CGM Data

      Medtronic Launches InPen with Real-Time Guardian Connect CGM Data

      Real-time glucose data coupled with InPen’s dose calculator helps users make better dosing decisions.
      Medtronic plc 11.12.20


    • Chronic Disease
      Novocure Earns CE Mark for NovoTTF-100L System

      Novocure Earns CE Mark for NovoTTF-100L System

      Helps treat unresectable, locally advanced or metastatic, malignant pleural mesothelioma.
      Business Wire 11.12.20

    • Chronic Disease
      Varian Invests $10M in COTA to Boost Data-Driven Cancer Care

      Varian Invests $10M in COTA to Boost Data-Driven Cancer Care

      Companies will work together to empower cancer clinics with data analytics and decision support tools.
      PR Newswire 11.10.20

    • Chronic Disease
      Exact Sciences to Acquire Thrive Earlier Detection

      Exact Sciences to Acquire Thrive Earlier Detection

      Announces plans to buy the rival company for $2.15 billion.
      Exact Sciences 10.27.20


    • Chronic Disease
      FDA Grants Breakthrough Device Designation to Cala Trio

      FDA Grants Breakthrough Device Designation to Cala Trio

      Aims to treat action tremors in the hands of adults with Parkinson's disease.
      Cala Health 10.22.20

    • Chronic Disease
      Varian Receives Investigational Device Exemption from FDA

      Varian Receives Investigational Device Exemption from FDA

      Prepares for first-ever clinical trial of FLASH Therapy.
      Varian 10.12.20

    • Chronic Disease | Patient Monitoring
      Dexcom, Eli Lilly Begin Program to Help Improve Diabetes Management

      Dexcom, Eli Lilly Begin Program to Help Improve Diabetes Management

      Companies will partner to promote Lyumjev, Lilly's new rapid-acting insulin, with Dexcom G6 CGM.
      PR Newswire 10.07.20


    Trending
    • FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System
    • Mike On Medtech: Update On FDA's STeP Designation
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Philips, Disney Join Forces To Reduce Childrens' MRI Anxiety
    • Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    Breaking News
    • Plastikos Medical Begins Phase II of Expansion
    • Ready Robotics Hires Proven Automation Leaders
    • Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety
    • FDA OKs Asensus' Senhance for General Surgery
    • Boston Scientific to Buy Lumenis' Surgical Biz for $1B
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preclinical Trial Suggests Fish Hydrolysate Attenuates Neuroinflammation Greater than DHA Alone
    Study Explains Link Between Probiotic Strains and Children’s Immune Health Benefits
    Maypro Launches Brain Heatlh Ingredient NeuroHD
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Matt Fogel Named Mule-Hide's Territory Manager – Southern Virginia
    Benjamin Moore Launches COMMAND
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Plastikos Medical Begins Phase II of Expansion
    Ready Robotics Hires Proven Automation Leaders
    Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Innoforce and dMed Enter Development Collaboration
    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    Four Female Leaders Appointed to Cell & Gene CDMO
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    BizBash Names Unfiltered Experience ‘People's Choice: Best Influencer Event’
    P&G Makes Progress Toward Packaging Circularity in Europe
    Coty Partners with LanzaTech to Introduce Sustainable Ethanol
    Happi

    Latest Breaking News From Happi

    Coty Partners with LanzaTech to Reduce Its Environmental Impact
    Waterless Beauty, Simplified Routines Shape Clean Beauty at Whole Foods
    Redken Updates Packaging, Adds New Products
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Fort Dearborn Company acquires Hammer Packaging
    Ashland announces PSA price hike in North America
    Arrow Systems and Sihl form flexible packaging partnership
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Joa Announces Expandable Absorbent Core Wrap Solution
    Principle Business Enterprises Celebrates 60 Years
    Mann+Hummel Invests in Pamlico Air
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lincotek Medical Expands Coatings and Additive Capacity
    Spinal Elements Relaunches the Luna XD and Orbit Systems
    Coronavirus Triggers Double-Digit Revenue Dropoff at Smith+Nephew
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login